KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 62 filers reported holding KITE PHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,747,000 | +22.5% | 35,000 | -30.0% | 0.54% | -5.5% |
| Q4 2016 | $2,242,000 | -19.7% | 50,000 | 0.0% | 0.57% | +24.8% |
| Q3 2016 | $2,793,000 | +11.7% | 50,000 | 0.0% | 0.46% | -29.9% |
| Q2 2016 | $2,500,000 | +8.9% | 50,000 | 0.0% | 0.65% | +30.3% |
| Q1 2016 | $2,296,000 | -25.5% | 50,000 | 0.0% | 0.50% | +10.4% |
| Q4 2015 | $3,081,000 | -2.9% | 50,000 | -12.2% | 0.45% | +11.4% |
| Q3 2015 | $3,172,000 | -8.7% | 56,970 | 0.0% | 0.40% | +19.1% |
| Q2 2015 | $3,473,000 | -8.7% | 56,970 | -13.6% | 0.34% | -14.1% |
| Q1 2015 | $3,805,000 | -40.5% | 65,970 | -40.6% | 0.40% | -63.7% |
| Q4 2014 | $6,400,000 | +230.4% | 110,970 | +63.3% | 1.09% | +356.1% |
| Q3 2014 | $1,937,000 | – | 67,970 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |